This article is more than 5 years old. Information may no longer be current.

Carl Zeiss Meditec boosts profitability in first half

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

JENA, Germany — Carl Zeiss Meditec more than doubled its net income in the first half of its fiscal year, from $3.6 million in 2003 to $7.8 million in 2004, according to a press release from the company. Group sales for the German company fell 3.8% from the same period a year ago, to $139.7 million. The decrease was attributed mostly to a strong euro, the company stated.

The improved results are attributed to “the product mix and the further optimization of manufacturing costs,” the company noted in its release.

In addition to the United States, “business has also been especially successful in Asia,” said Ulrich Krauss, president and chief executive officer of the company, in the release. “Despite the currency fluctuations, sales in this region came in at [$32.4 million], or 9.4% higher than in the previous year.”

The company’s chief technology officer, Walter Wrobel, MD, noted that Zeiss will be launching two products in the next few weeks. The ACMaster, based on the technology of the company’s IOLMaster, is designed for precise anterior eye segment measurements. The Preview PHP is designed for the early detection of age-related macular degeneration.